Welcome to MATRX Pharmaceuticals
Increasing Efficacy Through Novel Drug Delivery
How a drug is delivered can often be as important as what is delivered.
MATRX Pharmaceuticals, Inc. New York, N.Y. is a global pharmaceutical company focused on developing new drug products, as well as state of the art methods of drug delivery for existing medications. Specifically, Matrx's mission is to improve upon the longstanding methods of dosage forms (injections, tablets, gels, etc.), taken over several days or several times each day, by introducing products and systems that employ novel, controlled delivery strategies, which minimize administration and maximize therapy.
Our technologies form the basis of new drug delivery platforms for existing, approved medications with proven safety and efficacy data, significantly reducing the risks in obtaining drug regulatory marketing approvals as well as new, patentable drugs in order to achieve a leading market position and/or market exclusivity.
We employ our proprietary SĀPH™ platform and other differentiating technologies to provide additional proprietary, controlled-release products to a large underserved population in emerging markets. Matrx's products target a full range of administration formats (topical, vaginal, intramuscular, oral, etc.), providing relief to a wide variety of conditions while improving bioavailability and efficacy through improved controlled delivery mechanisms.
Our technologies boost the power of both new and existing drugs by making medicine with improved bioavailability and efficacy, allowing patients to take lower doses, saving money and potentially reducing side effects - Same Drugs, Better Results.